Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-02 10:20 am Purchase |
2020-12-31 | 13G | Envirotech Vehicles, Inc. ADOM |
Empery Asset Management, LP | 8,750,005 8.650% |
2,500,000 (+40.00%) |
Filing History |
| 2021-01-28 2:32 pm Sale |
2020-12-31 | 13G | U.S. Energy Corp. USEG |
Empery Asset Management, LP | 0 0.000% |
-157,905 (Position Closed) |
Filing History |
| 2021-01-28 2:31 pm Sale |
2020-12-31 | 13G | Asensus Surgical, Inc. ASXC |
Empery Asset Management, LP | 6,450,012 4.990% |
-2,121,416 (-24.75%) |
Filing History |
| 2021-01-28 2:30 pm Purchase |
2020-12-31 | 13G | Timber Pharmaceuticals, Inc. TMBR |
Empery Asset Management, LP | 181,706 9.990% |
154,398 (+565.40%) |
Filing History |
| 2021-01-28 2:27 pm Purchase |
2020-12-31 | 13G | SPI ENERGY CO LTD SHS SPIEF |
Empery Asset Management, LP | 1,165,000 4.980% |
177,000 (+17.91%) |
Filing History |
| 2021-01-28 2:25 pm Sale |
2020-12-31 | 13G | Salarius Pharmaceuticals, Inc. SLRX |
Empery Asset Management, LP | 4,022 3.900% |
-2,228 (-35.65%) |
Filing History |
| 2021-01-28 2:24 pm Sale |
2020-12-31 | 13G | Nano Dimension Ltd. NNDM |
Empery Asset Management, LP | 0 0.000% |
-4,200,000 (Position Closed) |
Filing History |
| 2021-01-28 2:21 pm Sale |
2020-12-31 | 13G | Medigus Ltd. MDGS |
Empery Asset Management, LP | 197,120 0.990% |
-3,480,657 (-94.64%) |
Filing History |
| 2021-01-26 11:23 am Sale |
2020-12-31 | 13G | Tiziana Life Sciences Ltd TLSA |
Empery Asset Management, LP | 0 0.000% |
-18,961,163 (Position Closed) |
Filing History |
| 2021-01-26 11:21 am Purchase |
2020-12-31 | 13G | Sonnet BioTherapeutics Holdings, Inc. SONN |
Empery Asset Management, LP | 2,316 4.990% |
2,098 (+960.62%) |
Filing History |
| 2021-01-26 11:18 am Purchase |
2020-12-31 | 13G | Seanergy Maritime Holdings Corp. SHIP |
Empery Asset Management, LP | 15,211 0.230% |
15,211 (New Position) |
Filing History |
| 2021-01-26 11:16 am Sale |
2020-12-31 | 13G | Ocugen, Inc. OCGN |
Empery Asset Management, LP | 0 0.000% |
-7,447,140 (Position Closed) |
Filing History |
| 2021-01-26 11:10 am Sale |
2020-12-31 | 13G | Safe & Green Holdings Corp. SGBX |
Empery Asset Management, LP | 0 0.000% |
-12,798 (Position Closed) |
Filing History |
| 2021-01-26 11:04 am Sale |
2020-12-31 | 13G | NanoViricides, Inc. NNVC |
Empery Asset Management, LP | 0 0.000% |
-640,000 (Position Closed) |
Filing History |
| 2021-01-26 10:59 am Sale |
2020-12-31 | 13G | MoSys, Inc. MOSY |
Empery Asset Management, LP | 7,375 0.210% |
-297,125 (-97.58%) |
Filing History |
| 2021-01-25 09:41 am Purchase |
2021-01-14 | 13G | Lantern Pharma Inc. LTRN |
Empery Asset Management, LP | 700,000 6.660% |
700,000 (New Position) |
Filing History |
| 2021-01-21 2:28 pm Purchase |
2021-01-15 | 13G | Titan Pharmaceuticals, Inc. TTNP |
Empery Asset Management, LP | 47,229 6.910% |
47,229 (New Position) |
Filing History |
| 2021-01-20 11:14 am Sale |
2020-12-31 | 13G | Moleculin Biotech, Inc. MBRX |
Empery Asset Management, LP | 33,223 4.570% |
-8,444 (-20.27%) |
Filing History |
| 2021-01-20 11:11 am Unchanged |
2021-12-31 | 13G | InMed Pharmaceuticals Inc. INM |
Empery Asset Management, LP | 44 4.990% |
0 (Unchanged) |
Filing History |
| 2021-01-20 11:10 am Sale |
2020-12-31 | 13G | Hepion Pharmaceuticals, Inc. HEPA |
Empery Asset Management, LP | 336 1.050% |
-1,664 (-83.21%) |
Filing History |